New-Onset Atrial Fibrillation Detected by Continuous Capnography Monitoring: A Case Report

Toby N. Weingarten; Hiroshi Morimatsu; Juan Fiorda-Diaz; Sergio D. Bergese; Makiko Ariyoshi; Juraj Sprung; Albert Dahan; Frank J. Overdyk

doi:10.12659/AJCR.925510

19 September 2020 : Case report USA

New-Onset Atrial Fibrillation Detected by Continuous Capnography Monitoring: A Case Report

Unusual clinical course, Challenging differential diagnosis, Unusual setting of medical care, Clinical situation which can not be reproduced for ethical reasons

Toby N. Weingarten^1ACDEF*, Hiroshi Morimatsu^2BCDE, Juan Fiorda-Diaz^3BCDE, Sergio D. Bergese^34ABCDE, Makiko Ariyoshi^2BCDE, Juraj Sprung^1CDE, Albert Dahan^5ACDE, Frank J. Overdyk^6ADE

DOI: 10.12659/AJCR.925510

Am J Case Rep 2020; 21:e925510

Authors information Article notes Copyright and License information

Related articles Order reprints Share article Share by email

View HTML version

Figure 1. Capnostream™ portable respiratory monitors used in the PRODIGY trial. (A) Capnostream™ 20p respiratory monitor. (B) Capnostream™ 35 portable respiratory monitor. Both monitors display continuous readings for end-tidal carbon dioxide (etCO2), respiratory rate, heart rate (HR), and oxyhemoglobin saturation (SpO2). ©2020 Medtronic. All rights reserved. Used with the permission of Medtronic.

Back to the Article

New-Onset Atrial Fibrillation Detected by Continuous Capnography Monitoring: A Case Report

Your Privacy